Phase II study of UFT with leucovorin and irinotecan (TEGAFIRI): first-line therapy for metastatic colorectal cancer
2007
Phase II study of UFT with leucovorin and irinotecan (TEGAFIRI): first-line therapy for metastatic colorectal cancer
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
23
References
19
Citations
NaN
KQI